PharmaFiles by Aussie17
Aussie17Exposing Big Pharma from the inside!
| Platform |  | Pricing | Only free issues | Publishes | Twice weekly |
|---|---|---|---|---|---|
| Issues | 264 | Subscribers | Read | aussie17.com |
Curious about how many subscribers PharmaFiles by Aussie17 has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #230 | |
| #62 |
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Dilbert Creator Dies at 68 After Cancer and Let me share Prostate Cancer Drug Sales.
The cartoonist who made millions laugh at the absurdities of office life, the pointless meetings, the evil bosses, the endless cubicle wars, died quietly at home in Pleasanton, California, on January 13, 2026. Scott Adams was 68. He had spe...
Shocking Twist: As mRNA Vaccine-Cancer Paper Explodes Worldwide, Pfizer Headhunter Contacts Critic Dr. Wafik El-Deiry
In my previous article, we looked at how peer-reviewed papers linking COVID vaccines to cancer faced censorship through cyberattacks and smears.
GLOBAL ALERT: Peer-Reviewed Bombshell Papers Reveal mRNA Vaccine Cancer Crisis – Journal Under Relentless Attack as Pharma Scrambles to Silence!
Japanese politician Mr Kazuhiro Haraguchi is a 10 times elected House of Representative from Saga’s 1st district, served as Minister of Internal Affairs and Communications under Prime Minister Yukio Hatoyama in 2009 overseeing telecommunica...
The Jab That Keeps on Giving: Part 2. Stroke drug skyrockets 200%!
Before proceeding with this article, I strongly recommend first reading Part 1 (linked here),
Similar Newsletters
Other publications recommended by the authors of this newsletter.
Authors
The writers behind this newsletter.
Big Pharma Exec Exposing the PHARMA INDUSTRIAL COMPLEX from the inside
Frequently Asked Questions
How can I access the email archive for PharmaFiles by Aussie17?
You can find recent issues that have been published by PharmaFiles by Aussie17 on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does PharmaFiles by Aussie17 have?
To see how many people subscribe to PharmaFiles by Aussie17, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in PharmaFiles by Aussie17?
Newsletter advertising can be extremely effective when it's done right. Before you pitch PharmaFiles by Aussie17 as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like PharmaFiles by Aussie17?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact PharmaFiles by Aussie17 using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to PharmaFiles by Aussie17?
Scroll up to where it says Similar Newsletters to see other publications like PharmaFiles by Aussie17. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact PharmaFiles by Aussie17?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.